The role of age and opioid agonist treatment on substance use treatment completion in the United States

References

• Abraham, A. J., Andrews, C. M., Yingling, M. E., & Shannon, J. (2018). Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees. Health Services Research, 53(1), 389–404. doi:https://doi.org/10.1111/1475-6773.12686
   PubMed Web of Science ®Google Scholar
• Arndt, S., Acion, L., & White, K. (2013). How the states stack up: Disparities in substance abuse outpatient treatment completion rates for minorities. Drug and Alcohol Dependence, 132(3), 547–554. doi:https://doi.org/10.1016/j.drugalcdep.2013.03.015
   PubMed Web of Science ®Google Scholar
• Baldini, A., Von Korff, M., & Lin, E. H. (2012). A review of potential adverse effects of long-term opioid therapy: A practitioner’s guide. Primary Care Companion for CNS Disorders, 14(3), 584–592. doi:https://doi.org/10.4088/PCC.11m01326
   Google Scholar
• Carew, A. M., & Comiskey, C. (2018). Treatment for opioid use and outcomes in older adults: A systematic literature review. Drug and Alcohol Dependence, 182, 48–57. doi:https://doi.org/10.1016/j.drugalcdep.2017.10.007
   PubMed Web of Science ®Google Scholar
• Chhatre, S., Cook, R., Mallik, E., & Jayadevappa, R. (2017). Trends in substance use admissions among older adults. BMC Health Services Research, 17(1), 584. doi:https://doi.org/10.1186/s12913-017-2538-z
   Google Scholar
• Choi, S., Adams, S. M., Morse, S. A., & MacMaster, S. (2015). Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders. Substance Use & Misuse, 50(5), 653–663. doi:https://doi.org/10.3109/10826084.2014.997828
   PubMed Web of Science ®Google Scholar
• Garrido, M. M., Kelley, A. S., Paris, J., Roza, K., Meier, D. E., Morrison, R. S., & Aldridge, M. D. (2014). Methods for constructing and assessing propensity scores. Health Services Research, 49(5), 1701–1720. doi:https://doi.org/10.1111/1475-6773.12182
   PubMed Web of Science ®Google Scholar
• Griffin, K. W. (2010). The epidemiology of substance use disorder among adolescents, and young adults: A developmental perspective. In L. M. Scheir (Ed.), Handbook of drug use etiology: Theory, methods and empirical findings (pp. 73–92). Washington, D.C.: American Psychological Association.
   Google Scholar
• Grogan, C. M., Andrews, C., Abraham, A., Humphreys, K., Pollack, H. A., Smith, B. T., & Friedmann, P. D. (2016). Survey highlights differences in medicaid coverage for substance use treatment and opioid use disorder medications. Health Affairs (Millwood), 35(12), 2289–2296. doi:https://doi.org/10.1377/hlthaff.2016.0623
   PubMed Web of Science ®Google Scholar
• Hamilton, A. B., & Grella, C. E. (2009). Gender differences among older heroin users. Journal of Women Aging, 21(2), 111–124. doi:https://doi.org/10.1080/08952840902837129
   PubMed Web of Science ®Google Scholar
• Han, B. H., Sherman, S. E., & Palamar, J. J. (2019). Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016. Preventive Medicine, 121, 94–98. doi:https://doi.org/10.1016/j.ypmed.2019.02.018
   PubMed Web of Science ®Google Scholar
• Howard, A. A., Hoover, D. R., Anastos, K., Wu, X., Shi, Q., Strickler, H. D., … Tien, P. C. (2010). The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women’s Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes, 54(2), 152–159. doi:https://doi.org/10.1097/QAI.0b013e3181d0c911
   PubMed Web of Science ®Google Scholar
• Huhn, A. S., Hobelmann, J. G., Strickland, J. C., Oyler, G. A., Bergeria, C. L., Umbricht, A., & Dunn, K. E. (2020). Differences in availability and use of medications for opioid use disorder in residential treatment settings in the United States. JAMA Network Open, 3(2), e1920843. doi:https://doi.org/10.1001/jamanetworkopen.2019.20843
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105(8), e55–e63. doi:https://doi.org/10.2105/ajph.2015.302664
   Web of Science ®Google Scholar
• Kandel, D. B., Griesler, P. C., Hu, M.-C., Kerridge, B. T., & Grant, B. F. (2017). Epidemiology of substance use disorders. In D. E. A. Charney (Ed.), Neurobiology of mental illness. New York: Oxford University Press.
   Google Scholar
• Kilpatrick, D., Acierno, R., Resnick, H., Saunders, B., & Best, C. (1997). A 2-year longitudinal analysis of the relationship between violent assault and substance use in women. Journal of Consulting and Clinical Psychology, 65(5), 834–847. doi:https://doi.org/10.1037/0022-006X.65.5.834
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., Lofwall, M. R., Havens, J. R., & Walsh, S. L. (2015). States’ implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug and Alcohol Dependence, 157, 36–43. doi:https://doi.org/10.1016/j.drugalcdep.2015.09.032
   PubMed Web of Science ®Google Scholar
• Kuerbis, A. (2020). Substance use among older adults: An update on prevalence, etiology, assessment, and intervention. Gerontology, 66(3), 249–258. doi:https://doi.org/10.1159/000504363
   PubMed Web of Science ®Google Scholar
• Leuven, E., & Sianesi, B. (2003). PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Statistical Software Components S432001, Boston College Department of Economics, revised 01 Feb 2018.
   Google Scholar
• Lowenstein, M., Kilaru, A., Perrone, J., Hemmons, J., Abdel-Rahman, D., Meisel, Z. F., & Delgado, M. K. (2019). Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey. American Journal of Emergency Medicine, 37(9), 1787–1790. doi:https://doi.org/10.1016/j.ajem.2019.02.025
   PubMed Web of Science ®Google Scholar
• Martin, B. C., Fan, M. Y., Edlund, M. J., Devries, A., Braden, J. B., & Sullivan, M. D. (2011). Long-term chronic opioid therapy discontinuation rates from the TROUP study. Journal of General Internal Medicine, 26(12), 1450–1457. doi:https://doi.org/10.1007/s11606-011-1771-0
   PubMed Web of Science ®Google Scholar
• Martins, S. S., Segura, L. E., Santaella-Tenorio, J., Perlmutter, A., Fenton, M. C., Cerdá, M., … Hasin, D. S. (2017). Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addictive Behaviors, 65, 236–241. doi:https://doi.org/10.1016/j.addbeh.2016.08.033
   PubMed Web of Science ®Google Scholar
• McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018). Sex and gender differences in substance use disorders. Clinical Psychology Review, 66, 12–23. doi:https://doi.org/10.1016/j.cpr.2017.10.012
   PubMed Web of Science ®Google Scholar
• Mennis, J., & Stahler, G. J. (2016). Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. Journal of Substance Abuse Treatment, 63, 25–33. doi:https://doi.org/10.1016/j.jsat.2015.12.007
   PubMed Web of Science ®Google Scholar
• Moyo, P. (2019). Opioid use disorder and its treatment among older adults: An invited commentary. American Journal of Geriatric Psychiatry, 27(4), 346–348. doi:https://doi.org/10.1016/j.jagp.2019.01.009
   PubMed Web of Science ®Google Scholar
• Mutter, R., Ali, M. M., Smith, K., & Strashny, A. (2015). Factors associated with substance use treatment completion in residential facilities. Drug and Alcohol Dependence, 154, 291–295. doi:https://doi.org/10.1016/j.drugalcdep.2015.07.004
   PubMed Web of Science ®Google Scholar
• NIDA. (2020). Opioid overdose crisis. Retrieved from https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis
   Google Scholar
• Pan, H., Gao, S., Grant, K., Novicoff, W., & Kang, H. (2018). Analyzing national and state opioid abuse treatment completion with multilevel modeling. Paper presented at the 2018 Systems and Information Engineering Design Symposium (SIEDS), Charlottesville, VA. doi:https://doi.org/10.1109/SIEDS.2018.8374721
   Google Scholar
• Pickard, J. G., Sacco, P., van den Berk-Clark, C., & Cabrera-Nguyen, E. P. (2020). The effect of legal mandates on substance use disorder treatment completion among older adults. Aging & Mental Health, 24(3), 497–503. doi:https://doi.org/10.1080/13607863.2018.1544209
   PubMed Web of Science ®Google Scholar
• Presnall, N. J., Wolf, D., Brown, D. S., Beeler-Stinn, S., & Grucza, R. A. (2019). A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings. Journal of Substance Abuse Treatment, 104, 135–143. doi:https://doi.org/10.1016/j.jsat.2019.06.010
   PubMed Web of Science ®Google Scholar
• Rejeski, W. J., & Fanning, J. (2019). Models and theories of health behavior and clinical interventions in aging: A contemporary, integrative approach. Clinical Interventions in Aging, 14, 1007–1019. doi:https://doi.org/10.2147/CIA.S206974
   PubMed Web of Science ®Google Scholar
• Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., … Stroke Statistics, S. (2012). Heart disease and stroke statistics–2012 update: A report from the American Heart Association. Circulation, 125(1), e2–e220. doi:https://doi.org/10.1161/CIR.0b013e31823ac046
   PubMed Web of Science ®Google Scholar
• Rowe, T. A., Jacapraro, J. S., & Rastegar, D. A. (2012). Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems. Addiction Science & Clinical Practice, 7(1), 22. doi:https://doi.org/10.1186/1940-0640-7-22
   PubMedGoogle Scholar
• Sacco, P., Kuerbis, A., & Harris, R. (2020). Older adults and substance misuse. In A. L. Begun, & M. M. Murray (Eds.), The Routledge handbook of social work and addictive behaviors . Chapter 15. New York: Routledge.
   Google Scholar
• Saloner, B., & Karthikeyan, S. (2015). Changes in Substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013. JAMA, 314(14), 1515–1517. doi:https://doi.org/10.1001/jama.2015.10345
   PubMed Web of Science ®Google Scholar
• Saunders, K. W., Dunn, K. M., Merrill, J. O., Sullivan, M., Weisner, C., Braden, J. B., … Von Korff, M. (2010). Relationship of opioid use and dosage levels to fractures in older chronic pain patients. Journal of General Internal Medicine, 25(4), 310–315. doi:https://doi.org/10.1007/s11606-009-1218-z
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., & McCabe, S. E. (2016). Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002-2003 and 2012-2013 National Survey on Drug Use and Health. Addictive Behaviors, 60, 219–222. doi:https://doi.org/10.1016/j.addbeh.2016.04.020
   PubMed Web of Science ®Google Scholar
• Scherrer, J. F., Salas, J., Copeland, L. A., Stock, E. M., Ahmedani, B. K., Sullivan, M., … Lustman, P. J. (2016). Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Annals of Family Medicine, 14, 54–62. doi:https://doi.org/10.1370/afm.1885
   PubMed Web of Science ®Google Scholar
• Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol use and heavy drinking during adolescence and the transition to young adulthood. Journal of Studies on Alcohol, Supplement, 14(supplement), 54–70. doi:https://doi.org/10.15288/jsas.2002.s14.54
   Google Scholar
• Simpatico, T. A. (2015). Vermont responds to its opioid crisis. Preventive Medicine, 80, 10–11. doi:https://doi.org/10.1016/j.ypmed.2015.04.002
   PubMed Web of Science ®Google Scholar
• Simpson, J. L., Grant, K. M., Daly, P. M., Kelley, S. G., Carlo, G., & Bevins, R. A. (2016). Psychological burden and gender differences in methamphetamine-dependent individuals in treatment. Journal of Psychoactive Drugs, 48(4), 261–269. doi:https://doi.org/10.1080/02791072.2016.1213470
   PubMed Web of Science ®Google Scholar
• Statacorp. (2018). Biprobit –Bivariate probit regression. College Station, TX: Statacorp LP. Retrieved from https://www.stata.com/manuals/rbiprobit.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration & Center for Behavioral Health Statistics and Quality. (2013). Treatment Episode Data Set (TEDS): 2001-2011. State admissions to substance abuse treatment services (BHSIS Series S-XX, HHS Publication No. (SMA) XX-XXXX). Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Sussman, S. (2013). A lifespan developmental-stage approach to tobacco and other drug abuse prevention. ISRN Addiction, 2013, 1–19. doi:https://doi.org/10.1155/2013/745783
   Google Scholar
• Tsui, J. I., Lira, M. C., Cheng, D. M., Winter, M. R., Alford, D. P., Liebschutz, J. M., … Samet, J. H. (2016). Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug and Alcohol Dependence, 166, 26–31. doi:https://doi.org/10.1016/j.drugalcdep.2016.06.024
   PubMed Web of Science ®Google Scholar
• Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. doi:https://doi.org/10.1080/10826084.2017.1363238
   PubMed Web of Science ®Google Scholar
• West, N. A., & Dart, R. C. (2016). Prescription opioid exposures and adverse outcomes among older adults. Pharmacoepidemiology and Drug Safety, 25(5), 539–544. doi:https://doi.org/10.1002/pds.3934
   PubMed Web of Science ®Google Scholar
• Weiner, J. Z., Gopalan, A., Mishra, P., Lipska, K. J., Huang, E. S., Laiteerapong, N., … Grant, R. W. (2019). Use and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes. JAMA Internal Medicine, 179(12), 1633–1641. doi:https://doi.org/10.1001/jamainternmed.2019.3759
   PubMed Web of Science ®Google Scholar
• Wooldridge, J. M. (2019). Introductory econometrics: A modern approach (7th ed.). UK: Nelson Education.
   Google Scholar
• Wu, L. T., Zhu, H., & Swartz, M. S. (2016). Treatment utilization among persons with opioid use disorder in the United States. Drug and Alcohol Dependence, 169, 117–127. doi:https://doi.org/10.1016/j.drugalcdep.2016.10.015
   PubMed Web of Science ®Google Scholar